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Abstract
‘Immunogenetics of Aging’ is a component that was first included in the 14th
International HLA and Immunogenetics Workshop (IHIWS) and developed further
within the 15th Workshop. The aim of this component was to assess the impact of
human leukocyte antigen (HLA) genes, cytokine genes, and some innate immunity
genes such as killer-cell immunoglobulin-like receptors (KIRs) and mannose-binding
lectin 2 (MBL2) in successful aging and their contribution to the better understanding
of immune dysfunction in old age. Within the 15th IHIWS new populations were
included in the analysis. Additional cytokine gene polymorphisms were assessed
and innate immunity genes were analyzed for possible relevance in longevity. The
results showed that longevity might be associated with anti-inflammatory cytokine
gene profiles, decreased frequency of interleukin-10 (IL-10) and transforming growth
factor-B1 haplotypes associated with a low level of gene expression, and increased
frequency of haplotypes determining a high level of expression. Extended tumor
necrosis factor-A and IL-12B genotypes were also likely relevant to longevity. Data
also showed that innate immunity genes are associated with susceptibility to infections
in the elderly and showed that these genes might be an important genetic marker in
aging. Decreased frequencies of KIR2DS5 and A1B10 haplotypes, and an increased
proportion of MBL2-deficient haplotypes were found in the group with higher
cytomegalovirus-specific IgG antibody levels. Together, these studies emphasize the
relevance of genes regulating immune functions in maintaining human longevity and
stress the importance of further clarifying their impact on successful aging.
The aging process is very complex and longevity is a multifac-
torial trait, which is determined by genetic and environmental
factors and the interaction of ‘disease’ processes with ‘intrin-
sic’ aging processes. Twin studies show that genes account
for 15–30% of human lifespan determination (1, 2). Many
studies showed that there are genetic differences between
centenarians and the general population. Additionally, fam-
ily studies showed that the siblings of centenarians have
a higher likelihood of reaching old age than the general
population (3). It is hypothesized that the level of immune
response influences longevity, and that this should therefore
be associated with genes regulating immune functions (4).
The ‘Immunogenetics of Aging’ program is a component
included within the 14th International HLA and Immuno-
genetics Workshop (IHIWS) developed further within the
15th. The aim of this component was to determine the contri-
bution of immune genes to successful aging and an increased
capacity to reach the extreme limits of lifespan. Two main
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data sets were collected: families with long-lived members
(octogenarians and nonagenarians) and unrelated elderly indi-
viduals compared with ethnically matched young controls. As
part of 14th IHIWS, the effect of classical human leuko-
cyte antigen (HLA) class I and class II loci and cytokine
polymorphisms in regulatory and/or coding regions, with a
possible impact on the level of gene expression of pro- and
anti-inflammatory cytokines, was analyzed. Results showed
that longevity in the populations studied is positively asso-
ciated with DRB1*11- and DRB1*16-associated haplotypes
and with increased anti-inflammatory cytokine genotypes (5).
During the 15th IHIWS, the number of samples collected was
increased, polymorphisms in cytokine genes and innate immu-
nity genes such as killer-cell immunoglobulin-like receptor
(KIR) and MBL2 were included in the analysis. Linkage
and association analyses were performed in order to iden-
tify extended immunogenetic profiles that could be relevant
to a better understanding of the mechanisms contributing to
successful aging and longevity.
Several previous studies had showed that cytokine dysreg-
ulation is associated with different disorders including age-
related disease. Increased interleukin-6 (IL-6) levels in the
elderly (6) are associated with the development of frailty and
susceptibility to diseases (7). Additionally, several investi-
gators reported increased ex vivo capacity of macrophages
from the elderly to produce IL-10 and increased trans-
forming growth factor-β (TGF-β) levels (6). On the other
hand, decreased capacity to produce interferon-γ (IFN-γ) was
observed in cells from the elderly upon stimulation. Studies
over the last few years have shown that polymorphisms in
the regulatory regions of cytokine genes could affect gene
transcription and cause different cytokine production lev-
els (8). Although some investigators have shown associations
of cytokine gene polymorphism with longevity, data are still
controversial and inconclusive (9–16).
This report will review the analyses of data collected by
the Immunogenetics of Aging Working Group. Results on
cytokine gene polymorphisms and innate immunity genes in
unrelated elderly and controls and families with long-lived
members are presented. Finally, the report will summarize the
future plans of the Immunogenetics of Aging Working Group.
Two main data sets were included in this study: unrelated
healthy elderly individuals and ethnically matched young
controls, and families with long-lived members. The following
selection criteria were used to identify families for the
study: extended families with a family history of at least
two generations with long-lived members (octogenarians and
nonagenarians) including elderly individuals, their children,
and grandchildren; availability of sufficient demographic data;
and data on family history of diseases. Elderly individuals
(in family-based analyses and unrelated case-control analyses)
were characterized according to the SENIEUR protocol (17).
The unrelated young controls were characterized according to
JUNIEUR protocol (17).
Table 1 Number of elderly and young individuals from each population
and testing performed within the component Immunogenetics of Aging
Number of individuals
Population Elderly Young Families
Genetic markers
analyzed
Bulgarians 60 100 12 families (three
generations)
HLAa, IL-2, IL-6,
IL-10, TNF-A,
TGF-B1, IFN-γ,
IL-12B, KIR, MBL2
Turkish 237 90 HLAa, TNF-A,
TGF-B1, IL-10, IL-6,
IFN-γ
Romanians 32 44 HLAa
Polish 129 HLAa, TNF-A, IL-6,
IFN-γ, IL-10
Italians 410 20 IL-10, IFN-γ, TNF-A,
IL-2, IL-12B, KIR
Irish 100 100 KIR
HLA, human leukocyte antigen; IFN-γ, interferon-γ; IL, interleukin; KIR,
killer-cell immunoglobulin-like receptor; MBL2,mannose-binding lectin 2;
TGF-B1, transforming growth factor-B1; TNF-A, tumor necrosis factor-A.
aHLA analysis was performed within the 14th IHIWS.
Data on six populations (the Bulgarian, Romanian, Polish,
Turkish, Italian, and Irish) are included in the component
Immunogenetics of Aging. During the 15th IHIWS, an addi-
tional 572 healthy randomly selected elderly individuals (aged
65–99) were collected. A total of 602 elderly, 393 young
controls, and 12 families with long-lived members, includ-
ing 17 unrelated elderly (65–90 years) and 23 family mem-
bers (18–57 years) were analyzed within this component. The
number of elderly and young individuals from each population
and the testing performed are given in Table 1.
In addition to the genetic markers HLA-A, -B, -DRB1,
-DQB1 loci, and single nucleotide polymorphisms (SNPs) in
cytokine genes possibly associated with the level of gene
expression [tumor necrosis factor-A (TNF-A); TGF-B1; IL-
10; IL-6; IFN-γ, IL-2] analyzed as a part of the 14th
IHIWS (5), extended genotypes in TNF-A, IL-12B, and TGF-
B1 genes were assessed and new genetic markers (MBL2 and
KIR) were included within the 15th IHIWS.
The additional single nucleotide gene polymorphisms
in cytokine genes TNF-A, TGF-B1, and IL-12B were
assessed by polymerase chain reaction-sequencing based typ-
ing (PCR-SBT) methods. KIR genotyping was performed by
PCR sequence-specific oligonucleotide (PCR-SSO) and PCR
sequence-specific primers (PCR-SSP) methods. For the anal-
ysis of MBL2 haplotypes, including six SNPs associated with
the protein level, a Luminex-based method was applied (18).
Allele frequencies were estimated by maximum-likelihood
analysis using the Arlequin program v1.1 (19). Standard
deviations were calculated from 100 bootstrap iterations.
Hardy–Weinberg equilibrium was tested by a hidden Markov
chain with 100,000 steps, implemented in the Arlequin
program. Arlequin software was also used to estimate
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maximum-likelihood three-locus haplotype frequencies from
genotypic data through an expectation-maximization (EM)
algorithm (20). Haplotypes were confirmed by inheritance
in families. Comparisons across different age groups were
assessed by the chi-squared test or Fischer exact test when
appropriate. A P-value lower than 0.05 was considered to
indicate a significant difference between groups. Bonferroni
correction for multiple comparisons was applied.
In this report we detail the major findings of the collabora-
tive study within the 15th IHIWS. Analysis of cytokine gene
polymorphisms in this study showed no statistically significant
differences between the elderly individuals and the control
groups from different populations for genotype frequencies
of the generally pro-inflammatory cytokines IL-2, IL-6, and
IFN-γ. However, associations with longevity were observed
for IL-10 haplotypes (Table 2), which were determined by
EM algorithm which had been validated in 12 families. The
IL-10 haplotype (−1082G, −819C, and −592C) associated
with high-level cytokine gene expression was significantly
more prevalent among healthy elderly to young controls (Pc <
0.05). These results were observed in both the Bulgarian and
the Turkish populations. Additionally, in Bulgarians the IL-10
haplotype (−1082A, −819T, and −592A), possibly related to
a lower level of gene expression, was found with slightly
lower frequency in the elderly. In the Turkish population,
a decreased frequency of another low-level IL-10 haplotype
(−1082A, −819C, and −592C) was observed in the elderly
(Pc < 0.05). The observations imply that longevity might be
associated with anti-inflammatory cytokine gene profiles.
Analysis of the extended TNF-A genotypes showed sig-
nificant differences between elderly individuals and young
controls. A genotype, possibly related to low-level expres-
sion, was more frequent among healthy elderly Bulgarians
compared with young controls (Table 3).
Analysis of genotypes of anti-inflammatory TGF-B1 also
showed possible association with aging. The genotype TGF-B1
(codon 10) T/T; (codon 25) G/G, related to high levels of
gene expression, was increased in elderly compared with
young controls (P < 0.05). In contrast there was a trend
to a lower frequency in elderly of the genotype TGF-B1
(codon 10) C/C; (codon 25) G/G, associated with low protein
level (Table 4). Analysis of extended TGF-B1 genotypes in
Table 2 IL-10 haplotypes in elderly and young controls
Haplotype frequency
Bulgarians Turkish
IL-10 (−1082; −819;
−592) haplotypes
Elderly
(n = 60)
Young
(n = 60)
Elderly
(n = 237)
Young
(n = 90)
ACC (low) 0.297 0.336 0.261∗∗ 0.364∗∗
ATA (low) 0.238∗ 0.358∗ 0.291 0.250
GCC (high) 0.466∗∗ 0.306∗∗ 0.487∗∗ 0.386∗∗
IL, interleukin.
∗P < 0.05, Pc = ns; ∗∗P < 0.01, Pc < 0.05.
Table 3 Extended TNF-A genotypes in elderly Bulgarians compared with
ethnically matched controls
TFN-A genotypes Genotype frequency
−1031 −863 −857 −308 +489
Elderly
(n = 60)
Young
(n = 50)
C/C A/A C/C G/G G/G 0.028 0.040
C/C C/A C/C G/G G/G∗∗ (low) 0.083 0.000
C/C C/C C/C G/G G/G 0.056 0.000
C/C C/C C/T G/G G/A 0.028 0.040
T/C A/A C/T G/G G/A 0.028 0.000
T/C C/A C/C G/A G/G 0.056 0.000
T/C C/A C/C G/G G/G∗ (low) 0.167 0.040
T/C C/A C/T G/G G/A 0.028 0.000
T/C C/C C/C G/G G/G 0.028 0.080
T/C C/C C/C G/A G/G 0.000 0.040
T/T C/C C/C A/A G/G 0.028 0.040
T/T C/C C/C G/A G/A 0.028 0.000
T/T C/C C/C G/A G/G 0.111 0.080
T/T C/C C/C G/G G/G 0.083 0.200
T/T C/C C/T G/A G/A 0.056 0.080
T/T C/C C/T G/G G/A 0.111 0.120
T/T C/C C/T G/G G/G 0.028 0.000
T/T C/C T/T G/G A/A 0.056 0.120
TNF-A, tumor necrosis factor-A.
∗P < 0.05, Pc = ns; ∗∗P < 0.01, Pc < 0.05.
Table 4 TGF-B1 genotypes in elderly compared with young controls
Genotype frequency
TGF-B1 genotypes Bulgarians Turkish
Codon 10 Codon 25
Elderly
(n = 60)
Young
(n = 40)
Elderly
(n = 237)
Young
(n = 90)
C/C C/C 0.000 0.000 0.004 0.011
C/C G/C 0.069 0.108 0.034 0.000
C/C G/G 0.172 0.216 0.131∗ 0.230∗
T/C C/C 0.000 0.000 0.008 0.000
T/C G/C 0.103 0.081 0.085 0.046
T/C G/G 0.396 0.459 0.347 0.483
T/T G/C 0.000 0.000 0.017 0.000
T/T G/G 0.259 0.135 0.373∗ 0.23∗
TGF-B1, transforming growth factor-B1.
∗P < 0.05, Pc = ns.
Bulgarians showed that genotype TGF-B1 (codon 10) C/C;
(codon 25) G/G; (−988) C/C; (−800) G/G was decreased,
while the genotype TGF-B1 (codon 10) T/C; (codon 25)
G/G; (−988) C/C; (−800) G/A was increased in elderly com-
pared with the controls (Table 5). Based on codon 10 and 25
these genotypes are associated with low- and high-level gene
expression, respectively. As the positions −988 and −800 are
located in the promoter region of the gene they could also
possibly modulate the expression of TGF-B1.
Analysis of IL-12B extended genotypes did not show any
statistically significant associations despite of the slightly
increased frequencies of (1188) C/C; (2124) A/A genotype in
elderly compared with young controls in both Bulgarians and
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Table 5 Extended TGF-B1 genotypes in elderly Bulgarians compared
with ethnically matched controls
TGF-B1 genotypes Genotype frequency
Codon 10 Codon 25 −988 −800
Elderly
(n = 60)
Young
(n = 40)
C/C G/C C/C G/G 0.034 0.056
C/C G/C C/T G/G 0.034 0.000
C/C G/G C/C G/G∗ (low) 0.085 0.254
C/C G/G C/T G/G 0.034 0.000
T/C G/C C/C G/A 0.017 0.028
T/C G/C C/C G/G 0.068 0.056
T/C G/G C/C G/A∗ (high) 0.051 0.000
T/C G/G C/C G/G 0.272 0.306
T/C G/G C/T G/G 0.034 0.028
T/T G/G C/C G/A 0.017 0.000
T/T G/G C/C G/G 0.167 0.139
T/T G/G C/T G/G 0.017 0.000
TGF-B1, transforming growth factor-B1.
∗P < 0.05, Pc = ns.
Italians. The functional relevance of the different distribution
of this genotype remains to be clarified.
As a part of the 15th IHWS some innate immune genes such
as KIR and MBL2 associated with susceptibility to infections
have been assessed as possible biomarkers related to aging.
KIR gene polymorphism was studied in two populations – one
in the north (Irish) and another in the south (Bulgarians). Com-
parison of KIR genotype distribution in the Irish cohort shows
significantly increased frequencies of KIR2DS3 (P < 0.05,
Pc = ns) and KIR2DL5 in the aged subset compared with the
young controls (Table 6), suggesting that these KIR genes may
play a role in successful aging in this population. On the other
hand, only a trend toward a higher frequency of KIR2DL2 and
lower KIR2DL3 and 2DS1 was observed in aged Bulgarians.
Further, analysis of KIR haplotype distribution was performed
in Bulgarians according to the model of Middleton et al. (21).
Increased frequencies of A1B1 [haplotype frequency (HF)
elderly = 0.136; HF controls = 0], A1B3 (HF elderly =
0.136; HF controls = 0.059), and A1B4 (HF elderly = 0.136;
HF controls = 0.059) and a decreased frequency of A1B10
(HF elderly = 0.091; HF controls = 0.176) profiles were
found in the elderly group but the differences were not sta-
tistically significant. Studies are now emerging supporting the
effect of the presence or absence of particular KIR genes on
the outcome of certain viral infections (22–28). However, lit-
tle is known about the role of KIR genetic background in the
control of cytomegalovirus (CMV) infection, which is strongly
implicated as part of the ‘immune risk profile’ in longitudi-
nal studies of elderly Swedes (29). It has been shown that
a donor KIR profile, containing either KIR2DS2 and 2DS4
or having ≥5 activating KIR genes is predictive for a low
risk of CMV reactivation in the recipient after hematopoietic
stem cell transplantation (24). In a case study of a child with
a novel immunodeficiency syndrome KIR2DL1 expression
on all natural-killer (NK) cells was associated with recurrent
Table 6 KIR gene frequencies in elderly and young controls from the
Irish population
KIR gene frequency
Young controls
(n = 100)
Elderly individuals
(n = 100)
KIR gene n (%) n (%)
2DL2 49 49.0 52 55.9
2DL3 93 93.0 82 88.2
2DS1 36 36.0 42 45.2
2DS2 49 49.0 52 55.9
2DS3∗ 25 25.0 38 40.9
2DS4 94 94.0 88 94.6
2DS5 28 28.0 32 34.4
3DS1 39 39.0 42 45.2
3DL1 94 94.0 87 93.5
2DL5 45 45.0 55 59.1
2DL4, 3DL2, 3DL3 100 100 93 93
KIR, killer-cell immunoglobulin-like receptors.
∗P < 0.05, Pc = ns.
CMV infection (25). As aging is associated with chronic, low-
grade inflammatory activity thought to be amplified by per-
sistent infection with CMV, the correlation between KIR and
CMV status in the elderly was analyzed (Figure 1). Decreased
frequencies of KIR2DS5 (P > 0.05) and A1B10 haplotypes
(P < 0.05, Pc = ns) were found in the group with higher (>20
IU/ml) CMV-specific IgG antibody levels. Taking into consid-
eration that KIR2DS5 is an activating receptor and the A1B10
haplotype is characterized by more inhibitory and less acti-
vating KIRs in comparison with the other AB profiles (except
A1B1), different mechanisms leading to the same effects on
persistent CMV could be applicable as previously suggested in
other viral infections (26–28). Interestingly, the presence of
the A1B10 profile in combination with HLA-DR11 and DR16
(alleles contained within longevity-associated HLA haplo-
types) was noted in individuals with low-grade CMV seropos-
itivity (<20 IU/ml). Along these lines, an association between
DRB1*1101/DQB1*0301 and HCV clearance has also been
reported (22). A possible explanation for this finding could be
that epistatic interactions between certain HLA and KIR hap-
lotypes may contribute to the generation of a more effective
immune response and suppression of a latent viral infection.
As KIRs act in combination with their ligands further efforts
to define associations between KIR/HLA ligand combinations
and CMV status will greatly enhance our ability to elucidate
the role of KIRs in successful aging.
It is well established that MBL serum levels are highly vari-
able and that they are genetically determined by six SNPs.
Three independent SNPs: cdn 52 (C/T; Arg/Cys, allele D);
cdn 54 (G/A; Gly>Asp, allele B); and cdn 57 (G/A; Gly>Glu,
allele C) disrupt the collagenous structure of the protein and
dramatically reduce serum MBL concentrations (30–32). Any
of these mutations (B, C, or D) is referred to as O, while the
wild type is referred to as A. In addition to exon one SNPs,
190 © 2011 John Wiley & Sons A/S · Tissue Antigens 77, 187–192
E. Naumova et al. Immunogenetics of Aging
Inhibitory KIRs
Activatory KIRs
Pr
op
or
tio
n 
o
f in
di
vi
du
al
s a
cc
o
rd
in
g 
to
 
a
n
ti-
CM
V 
a
n
tib
od
y t
ite
r 
0
10
20
30
40
50
60
70
80
90
100
2D
L1
2D
L2
2D
L3
2D
L4
2D
L5
3D
L1
3D
L2
3D
L3
CMV>22 IU/ml
CMV<22 IU/ml 
Pr
op
or
tio
n 
of 
ind
ivi
du
a
ls 
ac
co
rd
in
g 
to
 
a
n
ti-
CM
V 
an
tib
o
dy
 ti
te
r 
KIR genes 
0
10
20
30
40
50
60
70
80
90
100
2D
S1
2D
S2
2D
S3
2D
S4
2D
S5
3D
S1
2D
P1
3D
P1
CMV>22 IU/ml
CMV<22 IU/ml 
KIR genes 
Figure 1 Correlation of killer-cell immunoglobulin-like receptor (KIR)
gene distribution and the anti-cytomegalovirus (CMV) antibody titer.
Analysis of the distribution of KIR genes showed decreased frequencies
of KIR2DS5 (P = ns) in the group with higher (>20 IU/ml) CMV-specific
IgG antibody levels.
three regulatory variants in the promoter and in the 5′-UTR
regions at positions −619 (C/G; allele L/H), −290 (G/C;
allele Y/X), and −66 (C/T; allele P/Q) also influence final
serum MBL concentration. Combinations of these six SNPs
result in widespread haplotypes determining different serum
MBL levels (33, 34): deficiency (haplotypes LYPB, LYQC,
and HYPD); low level (haplotype LXPA); intermediate level
(haplotype LYPA); and high level (haplotypes HYPA and
LYQA). MBL allele and haplotype distribution is quite diverse
in different populations and MBL deficiency is one of the
most common immune deficiencies, the clinical consequences
of which have been extensively studied over the past few
years. As a part of the component ‘Immunogenetics of Aging’
we also sought associations of MBL2 polymorphisms and
CMV infections in elderly. Our preliminary results showed
that in the elderly, MBL2 haplotypes determining absence of
the protein (LYPB, LYQC, and HYPD) were more frequent in
those with a CMV antibody titer of >20 IU/μl compared with
those with a titer of <20 IU/ml (37% vs 26%, p-ns) (Figure 2).
Therefore, this might be studied further as a useful additional
relevant marker in aging.
In summary, our previous results suggest that longevity
is associated with HLA haplotypes shown to be protective
for diseases. Additionally, genotypes related to an enhanced
anti-inflammatory profile could be positively associated with
longevity. Extended genotypes are more informative in aging
because of their possible functional significance. Inheritance
of extended haplotypes in families with long-lived members
allowed us to identify immunogenetic profiles that could be
predictive of longevity. Innate immunity genes are associated
with susceptibility to infections and might be relevant genetic
markers in aging and longevity.
At the end of the 15th IHIW, a consensus was reached
on recommendations for future progress. A major challenge
in evaluating the large number of genes that are likely to
be picked up by the new techniques now available will be
to distinguish which of the many differences are involved in
the aging process, and which are a consequence of it. It was
concluded that additional samples/data from different ethnic
groups should be collected and additional, possibly function-
ally relevant polymorphisms in other genes such as TLR4,
CD14, CCR5, and MMP3 should be included. Expression
studies of IL and KIR genes would contribute to a more pre-
cise assessment of the influence of the genetic background on
human longevity.
References
1. Herskind AM, McGue M, Holm NV, Sørensen TI, Harvald
B, Vaupel JW. The heritability of human longevity: a
anti-CMV IgG <20 IU/ml 
46%
1%27%
26%
High
Intermediate
Low
Defficient
anti-CMV IgG >20 IU/ml 
40%
1%
22%
37%
Figure 2 Mannose-binding lectin 2 (MBL2) haplotype distribution and anti-cytomegalovirus (CMV) antibody levels in the elderly: high level of
MBL – HYPA, LYQA; intermediate level of MBL2 – LYPA; low level of MBL2 – LXPA; and deficiency of MBL2 – LYPB, LYQC, HYPD.
© 2011 John Wiley & Sons A/S · Tissue Antigens 77, 187–192 191
Immunogenetics of Aging E. Naumova et al.
population-based study of 2872 Danish twin pairs born
1870–1900. Hum Genet 1996: 97: 319–23.
2. Mitchell BD, Hsueh WC, King TM et al. Heritability of life
span in the Old Order Amish. Am J Med Genet 2001: 102:
346–52.
3. Perls TT, Wilmoth J, Levenson R et al. Life-long sustained
mortality advantage of siblings of centenarians. Proc Natl Acad
Sci U S A 2002: 99: 8442–7.
4. Modica M, Cammarata G, Caruso C. HLA-B8, DR3 phenotype
and lymphocyte responses to phytohaemagglutinin.
J Immunogenet 1990: 17: 101–7.
5. Naumova E, Pawelec G, Ivanova M et al. 14th International
HLA and Immunogenetics Workshop: report on the
Immunogenetics of Aging. Tissue Antigens 2007: 69 (Suppl 1):
304–10.
6. Forsey RJ, Thompson JM, Ernerudh J et al. Plasma cytokine
profiles in elderly humans. Mech Ageing Dev 2003: 124:
487–93.
7. Ershler WB, Keller ET. Age-associated increased interleukin-6
gene expression, late-life diseases, and frailty. Annu Rev Med
2000: 51: 245–70.
8. Bidwell J, Keen L, Gallagher G et al. Cytokine gene
polymorphism in human disease: on-line databases, supplement
1. Genes Immun 2001: 2: 61–70.
9. Lio D, Scola L, Crivello A et al. Gender-specific association
between −1082 IL-10 promoter polymorphism and longevity.
Genes Immun 2002: 3: 30–3.
10. Wang XY, Hurme M, Jylha M, Hervonen A. Lack of
association between human longevity and polymorphisms of
IL-1 cluster, IL-6, IL-10 and TNF-alpha genes in Finnish
nonagenarians. Mech Ageing Dev 2001: 123: 29–38.
11. Ross OA, Curran MD, Meenagh A et al. Study of
age-association with cytokine gene polymorphisms in an aged
Irish population. Mech Ageing Dev 2003: 124: 199–206.
12. Carrieri G, Marzi E, Olivieri F et al. The G/C915
polymorphism of transforming growth factor beta1 is
associated with human longevity: a study in Italian
centenarians. Aging Cell 2004: 3: 443–8.
13. Bonafe M, Olivieri F, Cavallone L et al. A gender-dependent
genetic predisposition to produce high levels of IL-6 is
detrimental for longevity. Eur J Immunol 2001: 31: 2357–61.
14. Rea IM, Ross OA, Armstrong M et al. Interleukin-6-gene C/G
174 polymorphism in nonagenarian and octogenarian subjects
in the BELFAST study. Reciprocal effects on IL-6, soluble
IL-6 receptor and for IL-10 in serum and monocyte
supernatants.Mech Ageing Dev 2003: 124: 555–61.
15. Bruunsgaard H, Benfield TL, Andersen-Ranberg K et al. The
tumor necrosis factor alpha −308G>A polymorphism is
associated with dementia in the oldest old. J Am Geriatr Soc
2004: 52: 1361–6.
16. Lio D, Scola L, Crivello A et al. Allele frequencies of
+874T→A single nucleotide polymorphism at the first intron
of interferon-gamma gene in a group of Italian centenarians.
Exp Gerontol 2002: 37: 315–9.
17. Ligthart GJ, Corberand JX, Fournier C et al. Admission
criteria for immunogerontological studies in man: the
SENIEUR protocol. Mech Ageing Dev 1984: 28: 47–55.
18. Ivanova M, Ruiqing J, Matsushita M et al. MBL2 single
nucleotide polymorphism diversity among four ethnic groups
as revealed by a bead-based liquid array profiling. Hum
Immunol 2008: 69: 877–84.
19. Shneider S, Rosseli JK, Excoffier L. Arlequin: A Software
Environment for the Analysis of Population Genetics Data.
Geneva: Genetics and Biometry Lab, 1996.
20. Slatkin M, Excoffier L. Testing for linkage disequilibrium in
genotypic data using the Expectation-Maximization algorithm.
Heredity 1996: 76: 377–83.
21. Middleton D, Williams F, Halfpenny IA. KIR genes. Transpl
Immunol 2005: 14: 135–42.
22. Martin MP, Carrington M. Immunogenetics of viral infections.
Curr Opin Immunol 2005: 17: 1–7.
23. Kulkarni S, Martin MP, Carrington M. The Yin and Yang of
HLA and KIR in human disease. Semin Immunol 2008: 20:
343–52.
24. Zaia JA, Sun JY, Gallez-Hawkins GM et al. The effect of
single and combined activating killer immunoglobulin-like
receptor genotypes on cytomegalovirus infection and immunity
after hematopoietic cell transplantation. Biol Blood Marrow
Transplant 2009: 15: 315–25.
25. Gazit R, Garty BZ, Monselise Y et al. Expression of KIR2DL1
on the entire NK cell population: a possible novel
immunodeficiency syndrome. Blood 2004: 103: 1965–66.
26. Khakoo SI, Thio CL, Martin MP et al. HLA and NK cell
inhibitory receptor genes in resolving hepatitis C virus
infection. Science 2004: 305: 842–4.
27. Romero V, Azocar J, Zuniga J et al. Interaction of NK
inhibitory receptor genes with HLA-C and MHC class II
alleles in Hepatitis C virus infection outcome. Mol Immunol
2008: 45: 2429–36.
28. Thio CL, Thomas DL, Carrington M. Chronic viral hepatitis
and the human genome. Hepatology 2000: 31: 819–27.
29. Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A.
Cytomegalovirus and human immunosenescence. Rev Med
Virol 2009: 19: 47–56.
30. Lipscombe RJSM, Hill AV, Lau YL, Levinsky RJ,
Summerfield JA, Turner MW. High frequencies in African and
non-African populations of independent mutations in the
mannose binding protein gene. Hum Mol Genet 1992: 1:
709–15.
31. Madsen HOGP, Kurtzhals JA, Lamm LU, Ryder LP, Thiel S,
Svejgaard A. A new frequent allele is the missing link in the
structural polymorphism of the human mannan-binding protein.
Immunogenetics 1994: 40: 37–44.
32. Sumiya MSM, Tabona P, Levinsky RJ, Arai T, Turner MW,
Summerfield JA. Molecular basis of opsonic defect in
immunodeficient children. Lancet 1991: 337: 1569–70.
33. Madsen HOGP, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP,
Svejgaard A. Interplay between promoter and structural gene
variants control basal serum level of mannan-binding protein.
J Immunol 1995: 155: 3013–20.
34. Madsen HOSM, Hogh B, Svejgaard A, Garred P. Different
molecular events result in low protein levels of
mannan-binding lectin in populations from southeast Africa
and South America. J Immunol 1998: 161: 3169–75.
192 © 2011 John Wiley & Sons A/S · Tissue Antigens 77, 187–192
